Moreover, SOCS2 promoted proliferation, anchorage-independent growth, apoptosis resistance, and in vivo tumor growth of prostate and colon cancer cell lines [42−44], testifying to its oncogenic potential. The gene discussed is SOCS2; the disease is colonic neoplasm.